HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, William G. Kaelin, Katarina Pinjušić et al.|Cell|2025Cited by 58
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenée Maria Saliby, David A. Braun, Chris Labaki et al.|Cancer Cell|2024Cited by 46
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, David A. Braun, Eddy Saad et al.|Journal of Clinical Oncology|2025Cited by 14
831 AXL Receptor Tyrosine Kinase Expression in Metastatic Renal Cell Carcinoma: Insights from the METEOR trialYasmin Nabil Laimon, Sabina Signoretti, Paul Morgan et al.|Laboratory Investigation|2025Cited by 2
Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic NeoplasmsChris Labaki, David A. Braun, Michel Alchoueiry et al.|The Oncologist|2023Cited by 2